Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Univ of North Carolina
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated:  3/3/2016
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Eosinophilic Esophagitis Databank
Eosinophilic Esophagitis (EoE) Databank (CoFAR 5)
Status: Enrolling
Updated: 3/3/2016
Mount Sinai School of Medicine
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Stanford University School of Medicine
2102
mi
from 43215
Palo Alto, CA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Stanford University School of Medicine
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Yale University
537
mi
from 43215
New Haven, CT
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Northwestern University Feinberg School of Medicine
274
mi
from 43215
Chicago, IL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Northwestern University Feinberg School of Medicine
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Chicago
270
mi
from 43215
Chicago, IL
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Iowa Hospital
460
mi
from 43215
Iowa City, IA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Iowa Hospital
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Maryland
343
mi
from 43215
Baltimore, MD
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Tufts Medical Center
642
mi
from 43215
Boston, MA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Drexel University
414
mi
from 43215
Philadelphia, PA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Drexel University
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Vanderbilt University
331
mi
from 43215
Nashville, TN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Vanderbilt University
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Virginia Mason Medical Center
2007
mi
from 43215
Seattle, WA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Virginia Mason Medical Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Status: Enrolling
Updated:  3/4/2016
St Luke's - Roosevelt Hospital Center
479
mi
from 43215
New York, NY
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Single Incision Laparoscopic Cholecystectomy Using a Flexible Endoscope and Ethicon Manually Articulating Devices (MAD)
Status: Enrolling
Updated: 3/4/2016
St Luke's - Roosevelt Hospital Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Yale University
552
mi
from 43215
Hartford, CT
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Yale University
552
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Yale University
537
mi
from 43215
New Haven, CT
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated:  3/7/2016
Baystate Medical Center
563
mi
from 43215
Springfield, MA
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Status: Enrolling
Updated: 3/7/2016
Baystate Medical Center
563
mi
from 43215
Springfield, MA
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
1171
mi
from 43215
Lakewood, CO
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
1171
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
993
mi
from 43215
Miami, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
797
mi
from 43215
Orlando, FL
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
797
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated:  3/7/2016
Lexicon Investigational Site
624
mi
from 43215
Minneapolis, MN
PK Study of Sotagliflozin in Subjects With Hepatic Impairment
A Phase 1, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Sotagliflozin in Male and Female Subjects With Mild, Moderate, and Severe Hepatic Impairment and Matched Subjects With Normal Hepatic Function
Status: Enrolling
Updated: 3/7/2016
Lexicon Investigational Site
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
243
mi
from 43215
Duncansville, PA
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
243
mi
from 43215
Duncansville, PA
Click here to add this to my saved trials
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Effects of Denosumab on the Pharmacokinetics of Etanercept
The Effects of Denosumab on the Pharmacokinetics of Etanercept in Postmenopausal Women With Low Bone Mineral Density and Rheumatoid Arthritis
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Secretin Infusion for Pain Due to Chronic Pancreatitis
Secretin Infusion for Pain Due to Chronic Pancreatitis
Status: Enrolling
Updated:  3/8/2016
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Secretin Infusion for Pain Due to Chronic Pancreatitis
Secretin Infusion for Pain Due to Chronic Pancreatitis
Status: Enrolling
Updated: 3/8/2016
Dartmouth Hitchcock Medical Center
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York University School of Medicine
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated:  3/8/2016
New York City Department of Correction
483
mi
from 43215
New York, NY
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
Status: Enrolling
Updated: 3/8/2016
New York City Department of Correction
483
mi
from 43215
New York, NY
Click here to add this to my saved trials
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated:  3/9/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated: 3/9/2016
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
University Hospitals Ahuja Medical Center
131
mi
from 43215
Beachwood, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
University Hospitals Ahuja Medical Center
131
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
University Hospitals Seidman Cancer Center
129
mi
from 43215
Cleveland, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
University Hospitals Seidman Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated:  3/9/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Effect of Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
Status: Enrolling
Updated: 3/9/2016
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
Status: Enrolling
Updated:  3/9/2016
NYU Langone Medical Center
478
mi
from 43215
New York, NY
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
Status: Enrolling
Updated: 3/9/2016
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated:  3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
278
mi
from 43215
Chapel Hill, NC
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
The Role of Serine-Proteases in Gastrointestinal Function and Irritable Bowel Syndrome
Status: Enrolling
Updated: 3/10/2016
University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology
278
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone? A Randomized Controlled Trial
Status: Enrolling
Updated:  3/10/2016
UPMC
165
mi
from 43215
Pittsburgh, PA
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone
Ischemic Foot Ulcers: Is Intervention Better Than Wound Care Alone? A Randomized Controlled Trial
Status: Enrolling
Updated: 3/10/2016
UPMC
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Therapeutic Hypothermia for Severe Acute Pancreatitis
Therapeutic Hypothermia for Severe Acute Pancreatitis: A Clinical Model for "Suspended Inflammation"
Status: Enrolling
Updated:  3/10/2016
NYU Medical Center
479
mi
from 43215
New York, NY
Therapeutic Hypothermia for Severe Acute Pancreatitis
Therapeutic Hypothermia for Severe Acute Pancreatitis: A Clinical Model for "Suspended Inflammation"
Status: Enrolling
Updated: 3/10/2016
NYU Medical Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated:  3/10/2016
NYU Medical Center
479
mi
from 43215
New York, NY
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Status: Enrolling
Updated: 3/10/2016
NYU Medical Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Barbara Ann Karmanos Cancer Center
164
mi
from 43215
Detroit, MI
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Barbara Ann Karmanos Cancer Center
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated:  3/10/2016
Charite -Universitätsmedizin Berlin
4334
mi
from 43215
Berlin,
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
A Phase 1, Multicenter, Open-label, Dose-escalation Study to Investigate the Safety and Pharmacokinetics of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia Secondary to Bile Duct Obstruction
Status: Enrolling
Updated: 3/10/2016
Charite -Universitätsmedizin Berlin
4334
mi
from 43215
Berlin,
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Karmanos Cancer Institute
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Duke Cancer Institute
354
mi
from 43215
Durham, NC
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Duke Cancer Institute
354
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Gabrail Cancer Center
103
mi
from 43215
Canton, OH
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Gabrail Cancer Center
103
mi
from 43215
Canton, OH
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Tennessee Oncology, PLLC
348
mi
from 43215
Nashville, TN
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Tennessee Oncology, PLLC
348
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated:  3/11/2016
Evergreen Hematology & Oncology
1778
mi
from 43215
Spokane, WA
Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Hepatic Impairment
An Open-Label, Single Arm, Phase 1 Study of the Pharmacokinetics and Safety of Carfilzomib in Subjects With Advanced Malignancies and Varying Degrees of Hepatic Impairment
Status: Enrolling
Updated: 3/11/2016
Evergreen Hematology & Oncology
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials